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T he metabolic syndrome is a constellation of interrelated abnormalities, including dyslipidemia, elevated blood pressure and glucose, and prothrombotic and proinflammatory states (1). Because of the growing prevalence of the metabolic syndrome, several organizations have attempted to set forth clinical criteria for its diagnosis (1-5). The most recent are those proposed by the International Diabetes Federation (IDF) definition (5) and the American Heart Association's National Heart, Lung, and Blood Institute (1). The latter updated the National Cholesterol Education Program Adult Treatment Panel III (ATPIII) criteria (2). Both IDF and updated ATPIII criteria emphasized the importance of adiposity in the etiology of the metabolic syndrome and recommended specific thresholds for central obesity in different ethnic groups. Thresholds in the two reports were identical for Asian populations. A significant difference between the two criteria is that the IDF makes central obesity necessary for diagnosis, whereas updated ATPIII criteria did not. Whether the prerequisite of central obesity has any impact on the prevalence or the classification of the syndrome in the Chinese population is unknown. The objective of this study is to assess the prevalence of the metabolic syndrome in the Chinese population using the ethnic-specific obesity definition for Chinese and to compare the agreement of diagnoses by IDF and ATPIII criteria.
RESEARCH DESIGN AND
METHODS -The Chinese Multiprovincial Cohort Study was a nationwide, multicenter, prospective cohort study on cardiovascular disease in China. The detailed information of the participants has been reported elsewhere (6 -8) . Briefly, a total of 29,564 subjects (aged 35-64 years) free of cardiovascular disease were recruited from 11 provinces in mainland China in 1992 for the baseline examination using the World Health Organization MONICA (Multinational Monitoring of Trends and Determinants in Cardiovascular Disease) protocol of risk factor survey (9, 10) . Complete data of anthropometric and metabolic measurements were available for 26,972 subjects (91.2% of the participants) and were used in this analysis.
Clinical criteria for the metabolic syndrome The updated ATPIII criteria for the diagnosis of metabolic syndrome (1) included three or more of the following: triglyceride Ն150 mg/dl (1.7 mmol/l), HDL cholesterol Ͻ40 mg/dl (1.03 mmol/l) in men and Ͻ50 mg/dl (1.29 mmol/l) in women, fasting glucose Ն100 mg/dl (5.6 mmol/l) or previously diagnosed with type 2 diabetes, blood pressure Ն130/85 mmHg or on antihypertensive medication, and central obesity (defined as waist circumference Ն90 cm in men and Ն80 cm in women, according to the ethnic criteria for Asians). The IDF requires central obesity (defined as waist circumference Ն90 cm in men and Ն80 cm in women for Asians, except for Japanese) plus two of the following four factors: triglycerides Ն150 mg/dl, HDL cholesterol Ͻ40 mg/dl in men and Ͻ50 mg/dl in women, fasting glucose Ն100 mg/dl or previously diagnosed with type 2 diabetes, and blood pressure Ն130/85 mmHg or on treatment for hypertension (5) .
Statistical analysis
Data are presented as means Ϯ SD or percentages. Age-standardized means or prevalence rates were calculated by the direct standardization method according to the distribution of the Chinese population in the 2000 China population census (11) . The agreement between the two definitions was tested by using , and the values were interpreted according to Landis and Koch (12) . All statistical analyses were carried out by using SPSS (version 12.0).
RESULTS -Among the 26,972 participants, 54.2% were men and 45.8% women. The mean age for men and women was 47.3 Ϯ 8.0 and 45.8 Ϯ 7.8 years, respectively.
The mean values of blood pressure, triglycerides, HDL cholesterol, fasting glucose, and waist circumference are presented in Table 1 , as well as the prevalence rates of the metabolic syndrome and its components. Elevated blood pressure and central obesity were the most prevalent components in men and women, respectively. According to the thresholds for Asians recommended by both criteria, 20.2% of men and 35.8% of women were classified as having central obesity. The age-standardized prevalence of the metabolic syndrome was 9.8% in men and 16.6% in women by IDF criteria, com-pared with rates of 14.4% in men and 20.0% in women by ATPIII criteria. Overall, ATPIII criteria diagnosed 4% more people with metabolic syndrome by detecting three or more metabolic components without the requirement of central obesity. The majority of the participants (95.3% of men and 96.7% of women) fell into the same category (either with or without metabolic syndrome) when diagnosed by the two criteria, given the same thresholds for central obesity (the thresholds for Asians). The agreement between the two diagnoses was "substantial" in men ( ϭ 0.786) and "almost perfect" in women ( ϭ 0.887).
CONCLUSIONS -In our study, one-fifth of men and one-third of women were classified as having central obesity using the ethnic criteria for Asians. Although the IDF places more emphasis on central obesity in the causation of the metabolic syndrome, our study indicated that the requirement of abdominal obesity did not increase the prevalence or the classification of the metabolic syndrome compared with ATPIII in this large Chinese population. Indeed, ATPIII identified somewhat more people with metabolic syndrome because three or more metabolic disorders were present without the coexistence of central obesity, the prerequisite of the IDF diagnosis. The majority of the participants fell into the same category when diagnosed by ATPIII and IDF. In other words, for the most part, the same individuals will be identified by either definition. This study demonstrates that the differences in diagnostic criteria by IDF and ATPIII are small when applied to the Chinese population. Data are means Ϯ SD, geometric mean (for triglycerides), or percent. *Age-standardized means and prevalence rates. †The value was significantly higher than that for the other sex (P Ͻ 0.05). BP, blood pressure; raised BP, BP Ն130/85 mmHg or on antihypertensive medication; raised triglycerides, triglycerides Ն150 mg/dl; raised fasting glucose, fasting glucose Ն100 mg/dl or previously diagnosed type 2 diabetes; reduced HDL cholesterol (Ͻ40/50 mg/dl), HDL cholesterol Ͻ40 mg/dl in men and Ͻ50 mg/dl in women; central obesity, waist circumference Ն90 cm in men and Ն80 cm in women.
